HomeSOBI • STO
add
Swedish Orphan Biovitrum AB (publ)
Nakaraang pagsara
kr 402.40
Sakop ng araw
kr 399.20 - kr 410.00
Sakop ng taon
kr 241.80 - kr 432.80
Market cap
146.54B SEK
Average na Volume
538.15K
P/E ratio
299.05
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 7.82B | 5.19% |
Gastos sa pagpapatakbo | 3.84B | -7.91% |
Net na kita | 1.86B | 33.21% |
Net profit margin | 23.79 | 26.61% |
Kita sa bawat share | 5.65 | 41.96% |
EBITDA | 3.22B | 37.27% |
Aktuwal na % ng binabayarang buwis | 14.24% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.04B | -8.68% |
Kabuuang asset | 67.43B | -10.62% |
Kabuuang sagutin | 29.71B | -15.47% |
Kabuuang equity | 37.72B | — |
Natitirang share | 345.66M | — |
Presyo para makapag-book | 3.69 | — |
Return on assets | 9.17% | — |
Return on capital | 12.48% | — |
Cash Flow
Net change in cash
| (SEK) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.86B | 33.21% |
Cash mula sa mga operasyon | 2.98B | 65.89% |
Cash mula sa pag-invest | -1.08B | -966.34% |
Cash mula sa financing | -1.90B | -65.13% |
Net change in cash | 2.00M | -99.63% |
Malayang cash flow | 2.43B | -16.30% |
Tungkol
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Itinatag
1939
Website
Mga Empleyado
1,888
